<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34947964</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">2075-1729</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>11</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Life (Basel, Switzerland)</Title>
          <ISOAbbreviation>Life (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bilateral Optic Disc Swelling as a Plausible Common Ocular Sign of Autoinflammatory Diseases: Report of Three Patients with Blau Syndrome or Cryopyrin-Associated Periodic Syndrome.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1433</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/life11121433</ELocationID>
        <Abstract>
          <AbstractText>The aim of this study is to describe bilateral optic disc swelling in three consecutive patients with Blau syndrome or cryopyrin-associated periodic syndrome at a single institution. Case 1 was a 30-year-old woman receiving 25 mg etanercept twice weekly who had been diagnosed as early-onset sarcoidosis by biopsy of skin rashes at 5 months old and genetically diagnosed with Blau syndrome with <i>CARD15</i>/<i>NOD2</i> mutation (N670K) at 13 years old. At 10 years old, she began to have uveitis with optic disc swelling in both eyes, resulting in macular degeneration and optic disc atrophy at 17 years old only when etanercept was introduced. Case 2 was a 21-year-old man receiving adalimumab every 2 weeks who had been diagnosed as early-onset sarcoidosis by biopsy of skin rashes at 1.5 years old and genetically diagnosed as Blau syndrome with <i>CARD15</i>/<i>NOD2</i> mutation (C495Y) at 5 years old. At 8 years old, around the time of adalimumab introduction, he began to show bilateral optic disc swelling which continued until the age of 16 years when the dose of adalimumab was increased. Case 3 was a 20-year-old woman receiving canakinumab every 8 weeks for systemic symptoms such as fever, headache, vomiting, and abdominal pain and later for sensorineural hearing disturbance on both sides. She had been diagnosed genetically with cryopyrin-associated periodic syndrome with <i>NLRP3</i> mutation (Y859C) at 7 years old. At 5 years old, she was found to have bilateral optic disc swelling, which continued until the age of 10 years when she began receiving canakinumab (IL-1β inhibitor). Bilateral optic disc swelling might be tentatively designated as a plausible common ocular feature, if it occurred, in autoinflammatory diseases to pay more attention to ophthalmic complications in rare diseases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Matsuo</LastName>
            <ForeName>Toshihiko</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0001-6570-0030</Identifier>
            <AffiliationInfo>
              <Affiliation>Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama City 700-8558, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Okayama University Hospital, Okayama City 700-8558, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yashiro</LastName>
            <ForeName>Masato</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Okayama University Hospital, Okayama City 700-8558, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamasaki</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <Identifier Source="ORCID">0000-0003-1595-933X</Identifier>
            <AffiliationInfo>
              <Affiliation>Melanoma Center, Department of Dermatology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama City 700-8558, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tanaka</LastName>
            <ForeName>Takehiro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama City 700-8558, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manki</LastName>
            <ForeName>Akira</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Okayama City Hospital, Okayama City 700-8557, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Life (Basel)</MedlineTA>
        <NlmUniqueID>101580444</NlmUniqueID>
        <ISSNLinking>2075-1729</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Blau syndrome</Keyword>
        <Keyword MajorTopicYN="N">CINCA/NOMID syndrome</Keyword>
        <Keyword MajorTopicYN="N">Muckle-Wells syndrome</Keyword>
        <Keyword MajorTopicYN="N">autoinflammatory diseases</Keyword>
        <Keyword MajorTopicYN="N">cryopyrin-associated periodic syndromes</Keyword>
        <Keyword MajorTopicYN="N">optic disc swelling (optic papillitis)</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>24</Day>
          <Hour>1</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34947964</ArticleId>
        <ArticleId IdType="pmc">PMC8709039</ArticleId>
        <ArticleId IdType="doi">10.3390/life11121433</ArticleId>
        <ArticleId IdType="pii">life11121433</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gattorno M., Federici S., Pelagatti M.A., Caorsi R., Brisca G., Malattia C., Martini A. Diagnosis and management of autoinflammatory diseases in childhood. J. Clin. Immunol. 2008;28:S73–S83. doi: 10.1007/s10875-008-9178-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10875-008-9178-3</ArticleId>
            <ArticleId IdType="pubmed">18368292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozen S., Bilginer Y. A clinical guide to autoinflammatory diseases: Familial Mediterranean fever and next-of-kin. Nat. Rev. Rheumatol. 2014;10:135–147. doi: 10.1038/nrrheum.2013.174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrrheum.2013.174</ArticleId>
            <ArticleId IdType="pubmed">24247370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pathak S., McDermott M.F., Savic S. Autoinflammatory diseases: Update on classification diagnosis and management. J. Clin. Pathol. 2017;70:1–8. doi: 10.1136/jclinpath-2016-203810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jclinpath-2016-203810</ArticleId>
            <ArticleId IdType="pubmed">27646526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarabishy A.B., Hise A.G., Traboulsi E.I. Ocular manifestations of the autoinflammatory syndromes. Ophthalmic Genet. 2012;33:179–186. doi: 10.3109/13816810.2012.695421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/13816810.2012.695421</ArticleId>
            <ArticleId IdType="pubmed">22924780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bascherini V., Granato C., Lopalco G., Emmi G., Vannozzi L., Bacherini D., Franceschini R., Iannone F., Salerni A., Molinaro F., et al.  The protean ocular involvement in monogenic autoinflammatory diseases: State of the art. Clin. Rheumatol. 2015;34:1171–1180. doi: 10.1007/s10067-015-2920-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-015-2920-3</ArticleId>
            <ArticleId IdType="pubmed">25833143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akiyama H., Seno A., Tada J., Arata J., Oda M. Sarcoidosis in a 6-month-old infant: Report of a case and review of the literature. Nihon Hifuka Gakkai Zasshi Jpn. J. Dermatol. 1993;103:19–25. (In Japanese)</Citation>
        </Reference>
        <Reference>
          <Citation>Yasui K., Yashiro M., Tsuge M., Manki A., Takemoto K., Yamamoto M., Morishima T. Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome. Arthritis Rheum. 2010;62:250–257. doi: 10.1002/art.25035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.25035</ArticleId>
            <ArticleId IdType="pubmed">20039400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanazawa N., Okafuji I., Kambe N., Nishikomori R., Nakata-Hizume M., Nagai S., Fuji A., Yuasa T., Manki A., Sakurai Y., et al.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: Common genetic etiology with Blau syndrome. Blood. 2005;105:1195–1197. doi: 10.1182/blood-2004-07-2972.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2004-07-2972</ArticleId>
            <ArticleId IdType="pubmed">15459013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okafuji I., Nishikomori R., Kanazawa N., Kambe N., Fujisawa A., Yamazaki S., Saito M., Yoshioka T., Kawai T., Sakai H., et al.  Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009;60:242–250. doi: 10.1002/art.24134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.24134</ArticleId>
            <ArticleId IdType="pubmed">19116920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuda T., Kambe N., Ueki Y., Kanazawa N., Izawa K., Honda Y., Kawakami A., Takei S., Tonomura K., Inoue M., et al.  Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann. Rheum. Dis. 2020;79:1492–1499. doi: 10.1136/annrheumdis-2020-217320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2020-217320</ArticleId>
            <ArticleId IdType="pubmed">32647028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa K., Gonzalez-Roca E., Souto A., Kawai T., Umebayashi H., Campistol J.M., Canellas J., Takei S., Kobayashi N., Callejas-Rubio J.L., et al.  Somatic NLRP3 mosaicism in Muckle-Wells syndrome: A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes. Ann. Rheum. Dis. 2015;74:603–610. doi: 10.1136/annrheumdis-2013-204361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-204361</ArticleId>
            <ArticleId IdType="pubmed">24326009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finetti M., Omenetti A., Federici S., Caorsi R., Gattorno M. Chronic infantile neurological cutaneous and articular (CINCA) syndrome: A review. Orphanet J. Rare Dis. 2016;11:167.  doi: 10.1186/s13023-016-0542-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-016-0542-8</ArticleId>
            <ArticleId IdType="pmc">PMC5142346</ArticleId>
            <ArticleId IdType="pubmed">27927236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yasumura J., Yashiro M., Okamoto N., Shabana K., Umebayashi H., Iwata N., Okura Y., Kubota T., Shimizu M., Tomiita M., et al.  Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: First report of the pediatric rheumatology association of Japan (PRAJ) Pediatr. Rheumatol. 2019;17:15.  doi: 10.1186/s12969-019-0318-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12969-019-0318-5</ArticleId>
            <ArticleId IdType="pmc">PMC6460824</ArticleId>
            <ArticleId IdType="pubmed">30975163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuo T., Yashiro M. Long-term control of macular edema with adalimumab after cataract surgery in a Japanese child with juvenile idiopathic arthritis: Case report and review of 26 Japanese patients. J. Investig. Med. High Impact Case Rep. 2020;8:2324709620953283.  doi: 10.1177/2324709620953283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2324709620953283</ArticleId>
            <ArticleId IdType="pmc">PMC7457411</ArticleId>
            <ArticleId IdType="pubmed">32862718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuo T. Fluorescein angiographic features of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology. 2002;109:132–136. doi: 10.1016/S0161-6420(01)00850-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(01)00850-8</ArticleId>
            <ArticleId IdType="pubmed">11772592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuo T., Matsuo N. Bilateral iridocyclitis with retinal capillaritis in juveniles. Ophthalmology. 1997;104:939–944. doi: 10.1016/S0161-6420(97)30203-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(97)30203-6</ArticleId>
            <ArticleId IdType="pubmed">9186433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurokawa T., Kikuchi T., Ohta K., Imai H., Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003;110:2040–2044. doi: 10.1016/S0161-6420(03)00717-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(03)00717-6</ArticleId>
            <ArticleId IdType="pubmed">14522785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snyers B., Dahan K. Blau syndrome associated with a CARD15/NOD2 mutation. Am. J. Ophthalmol. 2006;142:1089–1092. doi: 10.1016/j.ajo.2006.06.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2006.06.064</ArticleId>
            <ArticleId IdType="pubmed">17157607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillai P., Sobrin L. Blau syndrome-associated uveitis and the NOD2 gene. Semin. Ophthalmol. 2013;28:327–332. doi: 10.3109/08820538.2013.825285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08820538.2013.825285</ArticleId>
            <ArticleId IdType="pubmed">24010719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carreno E., Guly C.M., Chilov M., Hinchcliffe A., Arostegui J.I., Lee R.W.J., Dick A.D., Ramanan A.V. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome) Acta Ophthalmol. 2015;93:253–257. doi: 10.1111/aos.12544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/aos.12544</ArticleId>
            <ArticleId IdType="pubmed">25209167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarens I.L., Casteels I., Anton J., Bader-Meunier B., Brissaud P., Chedeville G., Cimaz R., Dick A.D., Espada G., Fernandez-Martin J., et al.  Blau syndrome-associated uveitis: Preliminary results from an international prospective interventional case series. Am. J. Ophthalmol. 2018;187:158–166. doi: 10.1016/j.ajo.2017.08.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2017.08.017</ArticleId>
            <ArticleId IdType="pubmed">28887115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeSouza P.J., Shah R. Characterization of Blau syndrome panuveitis with wide-field fluorescein angiography. Am. J. Ophthalmol. Case Rep. 2019;14:92–94. doi: 10.1016/j.ajoc.2019.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajoc.2019.03.006</ArticleId>
            <ArticleId IdType="pmc">PMC6447728</ArticleId>
            <ArticleId IdType="pubmed">30989150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pac Kisaarslan A., Sozeri B., Sahin N., Cicek S.O., Gunduz Z., Demirkaya E., Berdeli A., Ozcan S.S., Porazoglu H., Dusunsel R. Blau syndrome and early-onset sarcoidosis: A six case series and review of the literature. Arch. Rheumatol. 2019;35:117–127. doi: 10.5606/ArchRheumatol.2020.7060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5606/ArchRheumatol.2020.7060</ArticleId>
            <ArticleId IdType="pmc">PMC7322314</ArticleId>
            <ArticleId IdType="pubmed">32637927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suresh S., Tsui E. Ocular manifestations of Blau syndrome. Curr. Opin. Ophthalmol. 2020;31:532–537. doi: 10.1097/ICU.0000000000000705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/ICU.0000000000000705</ArticleId>
            <ArticleId IdType="pubmed">33009086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu S., Zhong L., Sun Z., Zhu T., Song H., Sui R. Ocular features in Chinese patients with Blau syndrome. Ocul. Immunol. Inflamm. 2020;28:79–85. doi: 10.1080/09273948.2019.1569239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2019.1569239</ArticleId>
            <ArticleId IdType="pubmed">30806112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jindal A.K., Pilania R.K., Suri D., Gupta A., Gattorno M., Ceccherini I., Kumar N., Bansal R., Nada R., Singh S. A young female with early onset arthritis, uveitis, hepatic, and renal granulomas: A clinical tryst with Blau syndrome over 20 years and case-based review. Rheumatol. Int. 2021;41:173–181. doi: 10.1007/s00296-019-04316-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-019-04316-6</ArticleId>
            <ArticleId IdType="pubmed">31062074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babu K., Rao A.P. Clinical profile in genetically proven Blau syndrome: A case series from south India. Ocul. Immunol. Inflamm. 2021;29:250–256. doi: 10.1080/09273948.2020.1746353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2020.1746353</ArticleId>
            <ArticleId IdType="pubmed">32293936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dollfus H., Hafner R., Hofmann H.M., Russo R.A.G., Denda L., Gonzales L.D., DeCunto C., Premoli J., Melo-Gomez J., Jorge J.P., et al.  Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome. Arch. Ophthalmol. 2010;118:1386–1392. doi: 10.1001/archopht.118.10.1386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archopht.118.10.1386</ArticleId>
            <ArticleId IdType="pubmed">11030821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oberg T.J., Vitale A.T., Hoffman R.O., Bohnsack J.F., Warner J.E. Cryopyrin-associated periodic syndromes and the eye. Ocul. Immunol. Inflamm. 2013;21:306–309. doi: 10.3109/09273948.2013.765016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09273948.2013.765016</ArticleId>
            <ArticleId IdType="pubmed">23662681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawai M., Yoshikawa T., Nishikomori R., Heike T., Takahashi K. Obvious optic disc swelling in a patient with cryopyrin-associated periodic syndrome. Clin. Ophthalmol. 2013;7:1581–1585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3743521</ArticleId>
            <ArticleId IdType="pubmed">23966762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wirths G., Grenzebach U., Eter N. Papillary edema in Muckle-Wells syndrome. Ophthalmologe. 2015;112:778–782. doi: 10.1007/s00347-014-3221-y. (In German)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00347-014-3221-y</ArticleId>
            <ArticleId IdType="pubmed">25614348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobolewska B., Angermair E., Deuter C., Doycheva D., Kuemmerle-Deschner J., Zierhut M. NLRP3 A439V mutation in a large family with cryopyrin-associated periodic syndrome: Description of ophthalmologic symptoms in correlation with other organ symptoms. J. Rheumatol. 2016;43:1101–1106. doi: 10.3899/jrheum.150681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3899/jrheum.150681</ArticleId>
            <ArticleId IdType="pubmed">27134254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez E.R., Corless B., Kontzias A., Cebulla C.M. Cryopyrin-associated periodic syndrome presenting with posterior scleritis. Rheumatology. 2019;58:2337–2339. doi: 10.1093/rheumatology/kez197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kez197</ArticleId>
            <ArticleId IdType="pmc">PMC6880849</ArticleId>
            <ArticleId IdType="pubmed">31170293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin W., Wu D., Luo Y., Zhao M., Wang Y., Shi X., Zhou L., Yu W., Sun Y., Wang R., et al.  Neurological manifestations of autoinflammatory diseases in Chinese adult patients. Semin. Arthritis Rheum. 2020;50:1500–1506. doi: 10.1016/j.semarthrit.2019.12.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2019.12.003</ArticleId>
            <ArticleId IdType="pubmed">32115236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cekic S., Yalcinbayir O., Kilic S.S. Ocular involvement in Muckle-Wells syndrome. Ocul. Immunol. Inflamm. 2020;28:70–78. doi: 10.1080/09273948.2018.1552305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2018.1552305</ArticleId>
            <ArticleId IdType="pubmed">30556770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma L., Lee S., Montieth A., Stephenson A., Foster C.S., Anesi S. Cryopyrin-associated periodic syndrome-associated uveitis and papillitis. Retin. Cases Brief Rep. 2021;15:149–154. doi: 10.1097/ICB.0000000000000756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/ICB.0000000000000756</ArticleId>
            <ArticleId IdType="pubmed">30134363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrushkin H., Stanford M., Fortune F., Jawad A.S. Clinical review: Familial Mediterranean fever: An overview of pathogenesis, symptoms, ocular manifestations, and treatment. Ocul. Immunol. Inflamm. 2016;24:422–430. doi: 10.3109/09273948.2015.1010012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09273948.2015.1010012</ArticleId>
            <ArticleId IdType="pubmed">25760918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basaran O., Kavuncu S., Guven A., Uncu N., Acar-Celikel B., Cakar N. Familial Mediterranean fever associated with optic neuritis, successfully treated with anti-interleukin 1 agents. Turk. J. Pediatr. 2016;58:327–330. doi: 10.24953/turkjped.2016.03.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.24953/turkjped.2016.03.018</ArticleId>
            <ArticleId IdType="pubmed">28266203</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
